Ignite Creation Date:
2024-05-06 @ 12:01 PM
Last Modification Date:
2024-10-26 @ 12:53 PM
Study NCT ID:
NCT03659136
Status:
COMPLETED
Last Update Posted:
2024-07-10
First Post:
2018-09-03
Brief Title:
The XENERA 1 Study Tests Xentuzumab in Combination With Everolimus and Exemestane in Women With Hormone Receptor Positive and HER2-negative Breast Cancer That Has Spread
Sponsor:
Organization:
Boehringer Ingelheim